CNS & Neurological Disorders - Drug Targets
Title:Meet Our Editorial Board Member
Volume: 15 Issue: 7
Author(s): Cinzia Volonté
Affiliation:
Export Options
About this article
Cite this article as:
Volonté Cinzia, Meet Our Editorial Board Member, CNS & Neurological Disorders - Drug Targets 2016; 15 (7) . https://dx.doi.org/10.2174/187152731507160808200100
DOI https://dx.doi.org/10.2174/187152731507160808200100 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
53
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Short Historical Survey of Developments in Amyloid Research
Protein & Peptide Letters Current Management of Traumatic Rupture of the Descending Thoracic Aorta
Current Cardiology Reviews Chemistry and Health Effects of Bioactive Compounds in Selected Culinary Aromatic Herbs
Current Nutrition & Food Science Pharmacology of Ampakine Modulators: From AMPA Receptors to Synapses and Behavior
Current Drug Targets Tau, Amyloid Beta and Deep Brain Stimulation: Aiming to Restore Cognitive Deficit in Alzheimer's Disease
Current Alzheimer Research Optimization of Microemulgel for Tizanidine Hydrochloride
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Synthesis of Chiral 3-Methyl- and 3-Methyl-N-propargyl-1,2,3,4- tetrahydroisoquinoline and Prevention of MPP+-Induced Cytotoxicity
Medicinal Chemistry Design, Synthesis, Characterization and Bioactivity Evaluation of New Symmetric Disulfonamides and Dicarbamates of 4,4'-Oxydianiline
Anti-Infective Agents Advanced Glycation End Products, Oxidative Stress and Metalloproteinases are altered in the Cerebral Microvasculature during Aging
Current Neurovascular Research Molecular Hydrogen as a Neuroprotective Agent
Current Neuropharmacology Neuropathic Pain: Some Clues for Future Drug Treatments
Mini-Reviews in Medicinal Chemistry Mitochondria as Therapeutic Targets of Estrogen Action in the Central Nervous System
Current Drug Targets - CNS & Neurological Disorders Microarray Data Analysis: Current Practices and Future Directions
Current Pharmacogenomics Influence of Adrenalectomy on Protective Effects of Urocortin I, a Corticotropin-Releasing Factor, Against Indomethacin-Induced Enteropathy in Rats
Current Neuropharmacology Creation of a putative third metal binding site in type II dihydroorotases significantly enhances enzyme activity
Protein & Peptide Letters Development of BACE1 Inhibitors for Alzheimers Disease
Current Medicinal Chemistry Developing Biomarkers for Methamphetamine Addiction
Current Neuropharmacology The Medicinal Chemistry of 5-HT6 Receptor Ligands with a Focus on Arylsulfonyltryptamine Analogs
Current Topics in Medicinal Chemistry Nitric Oxide (NO) System in Major Depression: Studies on NO Synthase Inhibitors as Antidepressant Agents
Current Enzyme Inhibition Development of Molecular Probes for Imaging Sigma-2 Receptors in Vitro and in Vivo
Central Nervous System Agents in Medicinal Chemistry